Optimizing the Treatment Sequence From Second-Line to Third-Line Therapy in Patients With Metastatic Colorectal Cancer: Discussion

被引：0
|
作者：
Grothey, Axel
Prager, Gerald W.
Yoshino, Takayuki
Bekaii-Saab, Tanios S.
机构：
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2020年 / 18卷 / 01期
关键词：
GLIOBLASTOMA;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：21 / 23
页数：3
相关论文
共 50 条
  • [21] Sequencing Considerations in the Third-Line Treatment of Metastatic Colorectal Cancer
    Barzi, Afsaneh
    Bekaii-Saab, Tanios
    AMERICAN JOURNAL OF MANAGED CARE, 2024, 30 (02): : S31 - S35
  • [22] Options for Second-Line Treatment in Metastatic Colorectal Cancer
    Lee, James J.
    Sun, Weijing
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (01) : 46 - 54
  • [23] A Decade of Progress: Advances in the Third-Line Treatment of Patients With Metastatic Colorectal Cancer
    Bekaii-Saab, Tanios
    AMERICAN JOURNAL OF MANAGED CARE, 2024, 30 (02): : S23 - S30
  • [24] Treatment of autoimmune hepatitis—First-line, second-line and third-line treatment
    Taubert R.
    Engel B.
    Die Innere Medizin, 2024, 65 (4) : 325 - 333
  • [25] Efficacy of bevacizumab in combination with irinotecan or oxaliplatin as second line, third-line or later treatment in metastatic colorectal cancer (MCRC) patients
    Lievre, A.
    Samalin, E.
    Senesse, P.
    Boyer-Gestin, C.
    Mitry, E.
    Lepere, C.
    Bachet, J.
    Vaillant, J.
    Ychou, M.
    Rougier, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [26] Second-line and third-line chemotherapy for lung cancer: Use and cost
    Ramsey, Scott D.
    Martins, Renato G.
    Blough, David K.
    Tock, Lauri S.
    Lubeck, Deborah
    Reyes, Carolina M.
    AMERICAN JOURNAL OF MANAGED CARE, 2008, 14 (05): : 297 - 306
  • [27] Cetuximab in third-line therapy of patients with metastatic colorectal cancer: A single institution experience
    Pantelic, Aleksandra
    Markovic, Milan
    Pavlovic, Milan
    Jancic, Snezana
    JOURNAL OF BUON, 2016, 21 (01): : 70 - 79
  • [28] First- and second-line therapy of metastatic colorectal cancer
    Terstriep, Shelby
    Grothey, Axel
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (06) : 921 - 930
  • [29] Beyond second-line therapy in patients with metastatic colorectal cancer: a systematic review
    Arnold, D.
    Prager, G. W.
    Quintela, A.
    Stein, A.
    Vera, S. Moreno
    Mounedji, N.
    Taieb, J.
    ANNALS OF ONCOLOGY, 2018, 29 (04) : 835 - 856
  • [30] BUDGET IMPACT ANALYSIS OF REGORAFENIB IN THE THIRD-LINE TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER
    Zhu, S.
    Liu, J.
    Sun, W.
    Xuan, J.
    VALUE IN HEALTH, 2018, 21 : S12 - S12
12345